Bayzed Health Group (HKSE:02609) Long-Term Debt: HK$82 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02609 Bayzed Health Group Inc HKSE:02609
12 GF Score
Price HK$2.96
! 3 Warning Signs
View Full Analysis

What is Bayzed Health Group Long-Term Debt?

Bayzed Health Group HKSE:02609 -0.34% 12 Long-Term Debt is HK$82 Mil as of Dec. 2025. GuruFocus rates HKSE:02609 with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Bayzed Health Group's Long-Term Debt for the quarter that ended in Dec. 2025 was HK$82 Mil.

Bayzed Health Group's quarterly Long-Term Debt increased from Dec. 2024 (HK$70 Mil) to Jun. 2025 (HK$118 Mil) but then declined from Jun. 2025 (HK$118 Mil) to Dec. 2025 (HK$82 Mil).

Bayzed Health Group's annual Long-Term Debt declined from Dec. 2023 (HK$103 Mil) to Dec. 2024 (HK$70 Mil) but then increased from Dec. 2024 (HK$70 Mil) to Dec. 2025 (HK$82 Mil).

Bayzed Health Group  (HKSE:02609) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Bayzed Health Group Long-Term Debt Related Terms

Bayzed Health Group Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Bayzed Health Group's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayzed Health Group Long-Term Debt Chart

Bayzed Health Group Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
136.18 83.04 102.86 69.51 81.75

Bayzed Health Group Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only 77.19 69.51 118.05 81.75 68.83
HKSE:02609
12GF Score
Bayzed Health Group Inc HKSE:02609
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of HK$82 Mil mean?
Bayzed Health Group (HKSE:02609) has a Long-Term Debt of HK$82 Mil as of Dec. 2025.
Is Bayzed Health Group's Long-Term Debt too high?
Bayzed Health Group's current Long-Term Debt is HK$82 Mil. Overall, Bayzed Health Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bayzed Health Group's Long-Term Debt compare to HCA and THC?
Bayzed Health Group's Long-Term Debt of HK$82 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Bayzed Health Group's current Long-Term Debt is HK$82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayzed Health Group stock overvalued right now?
Bayzed Health Group (HKSE:02609) has a current Long-Term Debt of HK$82 Mil. The current Long-Term Debt is HK$82 Mil. Bayzed Health Group's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Bayzed Health Group (HKSE:02609), the current Long-Term Debt is HK$82 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bayzed Health Group Business Description

Address No. 16 Lize Road, Room 2401, Mingfeng Tower Office Building, Fengtai District, Beijing, CHN
Bayzed Health Group Inc is an oncology healthcare group that principally engages in the investment in, and provision of, medical and healthcare related services in the PRC. It operates and manages a network of eight hospitals in Beijing, Tianjin, Shanxi Province, Anhui Province, and Henan Province, with a strategic focus on the provision of full-cycle oncology healthcare services through its direct ownership of the equity interest in six private for-profit hospitals and management over two private not-for-profit hospitals.
12GF Score

Get the complete analysis for HKSE:02609

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.96
Price